Movement Alert|Liquidia Technologies Rises 5.07% in Regular Trading, Rebounding After BofA Downgrade-Induced Selloff

Market Focus07-01

On June 30, Liquidia Technologies rose 5.07% in regular trading, trading at approximately $79.13 per share, with turnover of $34.12 million.

On the news front, the stock is rebounding after BofA Securities downgraded Liquidia from Buy to Neutral with a $79 price target the prior trading day, which triggered profit-taking and pushed shares down over 5% to around $73. The current recovery brings the stock back near the analyst target price level, suggesting the market has largely digested the rating adjustment.

Fundamentally, the company reported Q1 EPS of $0.52, beating the consensus estimate of $0.41 by approximately 27%. Core product YUTREPIA generated net product sales of approximately $130 million, with over 4,500 unique patient prescriptions, representing a swing to profitability year-over-year. The company also announced poster presentations at the PHA International PH Conference, providing additional catalysts. Despite the strong underlying performance, the downgrade suggests current valuation may fully reflect near-term positives.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment